Clinical Trial Update: Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States

View source ↗

Summary

A National Institute of Allergy and Infectious Diseases-sponsored clinical trial investigating Hyper-IgM Syndrome and Ectodermal Dysplasia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ectodermal Dysplasia
• Hyper-igm Syndrome

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hyper-IgM Syndrome, Ectodermal Dysplasia | Status: TERMINATED